• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Celgene

Oberland raises $800M for healthcare investments

September 6, 2018 By Nancy Crotti

Investment firm Oberland Capital said today that it has closed its second royalty and credit opportunities fund, Oberland Capital Healthcare II LP (Fund II), at its hard cap of $800 million in capital commitments. The fund will target investments between $20 million and $150 million with a focus on commercial stage or near-commercial stage biopharmaceutical, […]

Filed Under: Business/Financial News Tagged With: Celgene, melintatherapeutics, oberlandcapital

Here are the pharma companies accused of blocking generic competition

May 17, 2018 By Sarah Faulkner

To prove a generic drug is as safe and effective as the branded version, pharmaceutical companies have to hand over upwards of 1,000 doses of the product to a generic developer. But if the manufacturer creating the generic drug cannot get its hands on enough sample, the development and testing process slows down. It could […]

Filed Under: Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Actelion, Celgene, FDA, Gilead Sciences, GlaxoSmithKline plc, Johnson and Johnson, Novartis, Valeant Pharmaceuticals

Sunrise Labs executes succession plan | Personnel Moves – April 5, 2018

April 5, 2018 By Fink Densford

Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Abbott, AdvaMed, Alere, Brightree, Celgene, cerevasc, Cohera Medical Inc., Digirad Corp., IlluminOss Medical Inc., Johnson and Johnson, K2M, ResMed Inc., Smith & Nephew, Stryker, Sunrise Labs, Vascular Insights

Verily, Sanofi and other industry players team up with NIH to advance Parkinson’s therapies

January 30, 2018 By Sarah Faulkner

The National Institutes of Health is joining forces with the tech and pharmaceutical industries to speed the development of new drugs for Parkinson’s disease and identify biomarkers for the debilitating condition. Companies participating in the public-private partnership include Celgene (NSDQ:CELG), GlaxoSmithKline (NYSE:GSK), The Michael J. Fox Foundation for Parkinson’s Research, Pfizer (NYSE:PFE), Sanofi (NYSE:SNY) and Verily. Combined the groups plan to commit $12 million to […]

Filed Under: Clinical Trials, Diagnostics, Neurological, Pharmaceutical, Wall Street Beat Tagged With: Celgene, GlaxoSmithKline plc, National Institutes of Health (NIH), Pfizer, Sanofi-Aventis, Verily

Novocure brings Optune tech to drug trial for glioblastoma

July 24, 2017 By Sarah Faulkner

Novocure (NSDQ:NVCR) said today that it joined a Phase Ib study to evaluate the safety of Celgene‘s (NSDQ:CELG) marizomib and temozolomide in combination with Optune for patients with newly-diagnosed glioblastoma. The trial is the first to assess Optune, the company’s “Tumor Treating Fields” delivery device, in combination with an investigational drug. Get the full story at our […]

Filed Under: Clinical Trials, Drug-Device Combinations, Neurological, Oncology, Pharmaceutical, Wall Street Beat Tagged With: Celgene, NovoCure

Leukemia trial to match patients with drugs based on genetic biomarkers

July 19, 2017 By Sarah Faulkner

The Leukemia & Lymphoma Society said today that its expanding its Beat AML Master trial to include five investigational treatments for acute myeloid leukemia. The trial, which launched in October last year, has enrolled 70 patients and has garnered support by Alexion Pharmaceuticals (NSDQ:ALXN), Boehringer Ingelheim, Celgene (NSDQ:CELG) and Gilead Sciences (NSDQ:GILD), all of which are providing investigational AML treatments. The non-profit […]

Filed Under: Clinical Trials, Oncology, Pharmaceutical, Wall Street Beat Tagged With: alexionpharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Celgene, Gilead Sciences

Celgene acquires Delinia, beats on Q4 earnings

January 27, 2017 By Sarah Faulkner

Shares in Celgene (NSDQ:CELG) fell yesterday, even though the biopharmaceutical company beat earnings expectations on Wall Street with its 4th quarter results. The Summit, N.J.-based company posted profits of $1.29 million, or $1.61 per share, on sales of $2.9 million for the 3 months ended Dec. 31, for bottom-line growth of 34% on sales growth […]

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: Celgene

Evotec, Celgene ink drug development deal for stem cell treatments for neurodegenerative diseases

December 16, 2016 By Sarah Faulkner

Evotec (ETR:EVT) said today that it inked a 5-year drug discovery and development deal with Celgene (NSDQ:CELG) to identify stem cell therapies for a range of neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease. According to the agreement, Hamburg, Germany-based Evotec will receive an upfront payment of $45 million and Celgene will hold exclusive […]

Filed Under: Distribution, Drug-Device Combinations, Pharmaceutical, Stem Cells, Wall Street Beat Tagged With: Celgene, Evotec

Celgene invests in GNS

November 29, 2016 By Sarah Faulkner

Celgene (NSDQ:CELG) said this week that it has made another investment in GNS Healthcare and inked a deal with the bioanalytics firm for its “Reverse Engineering and Forward Simulation” software. GNS’s software analyzes health data, including electronic health records, pharmacy claims and genomic sequences, and uses machine learning to answer questions in healthcare. The multi-year agreement […]

Filed Under: Big Data, Funding Roundup Tagged With: Celgene, GNS Healthcare

Misonix CEO steps down | Personnel Moves October 4, 2016

October 4, 2016 By Sarah Faulkner

Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a member of the board of directors, is serving as the interim CEO while negotiating for a full-time position in the corner office. Vizirgiankis, who owned […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: Acceleron Pharma, Bayer, Celgene, iCad Inc., Medtronic, Misonix, Navidea Biopharmaceuticals, Urologix Inc., West Pharmaceutical Services Inc.

Celgene inks collab deal with EMR firm Trinetx

May 25, 2016 By Fink Densford

Celgene (NSDQ:CELG) said today it inked a collaborative deal with TriNetX to develop advanced clinical trial design for Celgene’s next-gen therapeutic programs. Through the deal, Celgene will be able to access medical data from electronic medical records through TriNetX’s proprietary network of healthcare institutions, the companies said. “TriNetX represents the future of a data-driven approach to […]

Filed Under: Business/Financial News, Clinical Trials, Research & Development Tagged With: Celgene

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS